Company receives funding for next-generation drug discovery platform that uses artificial intelligence technology
Investment will enable company to scale-up its platform to screen more targets and diseases than they were previously capable of
Please sign in or register for FREE
Sign in to MedChemNet
Register to MedChemNet
MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.